Emergent drug panel-V2 kits and laboratory support services EO 14398

Active Purchase Order Awarded Last action

Contract number
75D30126P21602
Awardee
Awarding agency
Obligated
$215,650

Award facts

Contract value 62% obligated
  • $215,650.00 Current, with exercised options
  • $349,150.00 Potential, with all options
Completion date 2% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Ann Arbor, MI 48108, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Centers for Disease Control and Prevention Pittsburgh awarded a purchase order to Cayman Chemical Co Inc. for Emergent Drug Panel-V2 kits and laboratory support services on September 30, 2026, with a ceiling value of $349,150 and ultimate completion date of September 29, 2030. Work is performed in Ann Arbor, Michigan. The order is firm fixed price with no small business set-aside. No Service Contract Inventory data accompanies this award.

Quick answers

Who was awarded contract 75D30126P21602?

75D30126P21602 was awarded to Cayman Chemical Co Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 30, 2026.

How much is contract 75D30126P21602 worth?

The government has obligated $215,650 on 75D30126P21602. Its potential value, with all options, is $349,150.

Was contract 75D30126P21602 competed?

The extent of competition for 75D30126P21602 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award